home All News open_in_new Full Article

[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling inflammatory diseases Despite FDA approval nearly a decade ago, […]


today 32 h. ago attach_file Science

attach_file Other
attach_file Economics
attach_file Events
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Society
attach_file Sport
attach_file Other
attach_file Society
attach_file Other
attach_file Politics
attach_file Science
attach_file Other
attach_file Politics
attach_file Other
attach_file Science
attach_file Transport
attach_file Culture


ID: 4113111304
Add Watch Country

arrow_drop_down